Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ARVINAS, INC.ARVN · Entity 5355 | Chief Financial Officer | February 23, 2024 | February 27, 2024 |
| HOOKIPA Pharma Inc.HOOK · Entity 15295 | Director | July 22, 2024 | July 24, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ARVINAS, INC.
Report date February 23, 2024 · Filed February 27, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 181,916 |
Reported balance
After 2024-02-23 transaction · row 1
1 source rowRow 1 · 2024-02-23 · Sale · Disposed 1,702 · Balance 181,916 F1: This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units. |
Filing footnotes · ownership attribution and instrument terms
F1: This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units.
HOOKIPA Pharma Inc.
Report date July 22, 2024 · Filed July 24, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.44 · Expires 2034-07-22 | Direct | 9,800 |
Reported balance
After 2024-07-22 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-07-22 · Grant · Acquired 9,800 · Balance 9,800 F1: The shares subject to this option will vest in thirty-six equal monthly installments commencing July 22, 2024, subject to Reporting Person's continuous service through each such date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to this option will vest in thirty-six equal monthly installments commencing July 22, 2024, subject to Reporting Person's continuous service through each such date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 22, 2024 Filed Jul 24, 2024 16:16 UTC | HOOKIPA Pharma Inc. HOOK · Entity 15295 | GrantStock Option (Right to Buy) · Derivative | 9,800 | $0.00 Strike: $6.44 | $0.00 |
DisclosureSEC source: 0001415889-24-020041 · form4-07242024_080718.xml · derivative · entry 1 Cassidy Sean A · CIK 0001421914 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,800 Underlying: Common Stock · 9,800 shares Expires 2034-07-22 F1 · derivative.exercise_date: The shares subject to this option will vest in thirty-six equal monthly installments commencing July 22, 2024, subject to Reporting Person's continuous service through each such date. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 18:34 UTC | ARVINAS, INC. ARVN · Entity 5355 | SaleCommon Stock | 1,702 | $47.05 | $80,079.10 |
DisclosureSEC source: 0001655759-24-000027 · wk-form4_1709076882.xml · nonDerivative · entry 1 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 181,916 F1 · shares: This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:49 UTC | ARVINAS, INC. ARVN · Entity 5355 | Exercise / conversionRestricted Stock Units · Derivative | 4,791 | $0.00 | $0.00 |
DisclosureSEC source: 0001655759-23-000024 · wf-form4_167789814910051.xml · derivative · entry 3 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,791 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: On March 1, 2019, the reporting person was granted 19,165 Restricted Stock Units, vesting in four equal annual installments beginning March 1, 2020. F4 · derivative.expiration_date: On March 1, 2019, the reporting person was granted 19,165 Restricted Stock Units, vesting in four equal annual installments beginning March 1, 2020. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:49 UTC | ARVINAS, INC. ARVN · Entity 5355 | SaleCommon Stock | 1,745 | $29.53 | $51,529.85 |
DisclosureSEC source: 0001655759-23-000024 · wf-form4_167789814910051.xml · nonDerivative · entry 2 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,618 F2 · shares: This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units. F3 · price: The broker sold shares of the Issuer's common stock for certain employees following the vesting of previously granted Restricted Stock Units, including the common stock reported on this Form 4 by the reporting person, at a price of $29.53. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:49 UTC | ARVINAS, INC. ARVN · Entity 5355 | Exercise / conversionCommon Stock | 4,791 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001655759-23-000024 · wf-form4_167789814910051.xml · nonDerivative · entry 1 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,363 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 16:59 UTC | ARVINAS, INC. ARVN · Entity 5355 | GrantStock Option (right to buy) · Derivative | 57,450 | $0.00 Strike: $34.37 | $0.00 |
DisclosureSEC source: 0001655759-23-000020 · wf-form4_167727595596926.xml · derivative · entry 2 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,450 Underlying: Common Stock · 57,450 shares Expires 2033-02-21 F2 · derivative.exercise_date: The option was granted by the Issuer on February 22, 2023, pursuant to the Plan. The shares underlying the option will vest over four years: 1/4 of the shares underlying the award shall vest on February 22, 2024, with the remainder of the shares vesting in equal monthly installments following February 22, 2024 through February 23, 2027. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 16:59 UTC | ARVINAS, INC. ARVN · Entity 5355 | GrantCommon Stock | 19,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001655759-23-000020 · wf-form4_167727595596926.xml · nonDerivative · entry 1 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,572 F1 · shares: The restricted stock units (each, an "RSU") were granted by the Issuer on February 22, 2023, pursuant to its 2018 Stock Incentive Plan (the "Plan") and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs will vest over four years: 1/4 of the shares underlying the award shall vest on February 22, 2024, with the remainder of the shares vesting in equal monthly installments following February 22, 2024 through February 23, 2027. Read SEC document |
| March 11, 2022 Filed Mar 15, 2022 20:00 UTC | ARVINAS, INC. ARVN · Entity 5355 | Exercise / conversionStock Option (right to buy) · Derivative | 15,000 | $16.00 Strike: $16.00 | $240,000.00 |
DisclosureSEC source: 0001209191-22-018995 · doc4.xml · derivative · entry 3 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,710 Underlying: Common Stock · 15,000 shares Expires 2028-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2021. F3 · derivative.exercise_date: This option award was granted on September 26, 2018, and the shares underlying the award were fully vested upon grant. Read SEC document |
| March 11, 2022 Filed Mar 15, 2022 20:00 UTC | ARVINAS, INC. ARVN · Entity 5355 | SaleCommon Stock | 15,000 | $70.00 | $1,050,000.00 |
DisclosureSEC source: 0001209191-22-018995 · doc4.xml · nonDerivative · entry 2 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,447 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2021. Read SEC document |
| March 11, 2022 Filed Mar 15, 2022 20:00 UTC | ARVINAS, INC. ARVN · Entity 5355 | Exercise / conversionCommon Stock | 15,000 | $16.00 | $240,000.00 |
DisclosureSEC source: 0001209191-22-018995 · doc4.xml · nonDerivative · entry 1 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,447 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2021. Read SEC document |
| March 04, 2022 Filed Mar 4, 2022 21:00 UTC | ARVINAS, INC. ARVN · Entity 5355 | Exercise / conversionRestricted Stock Units · Derivative | 4,791 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-016531 · doc4.xml · derivative · entry 4 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,791 Underlying: Common Stock · 4,791 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: On March 1, 2019, the reporting person was granted 19,165 Restricted Stock Units, vesting in four equal annual installments beginning March 1, 2020. F5 · derivative.expiration_date: On March 1, 2019, the reporting person was granted 19,165 Restricted Stock Units, vesting in four equal annual installments beginning March 1, 2020. Read SEC document |
| March 04, 2022 Filed Mar 4, 2022 21:00 UTC | ARVINAS, INC. ARVN · Entity 5355 | SaleCommon Stock | 1,593 | $63.94 | $101,856.42 |
DisclosureSEC source: 0001209191-22-016531 · doc4.xml · nonDerivative · entry 2 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,447 F2 · shares: This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units. F3 · price: The broker sold shares of the Issuer's common stock for certain employees following the vesting of previously granted Restricted Stock Units, including the common stock reported on this Form 4 by the reporting person, at an average price of $63.94. Read SEC document |
| March 04, 2022 Filed Mar 4, 2022 21:00 UTC | ARVINAS, INC. ARVN · Entity 5355 | Exercise / conversionCommon Stock | 4,791 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-016531 · doc4.xml · nonDerivative · entry 1 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,040 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 23, 2022 Filed Mar 4, 2022 21:00 UTC | ARVINAS, INC. ARVN · Entity 5355 | GrantStock Option (right to buy) · Derivative | 67,000 | $0.00 Strike: $64.19 | $0.00 |
DisclosureSEC source: 0001209191-22-016531 · doc4.xml · derivative · entry 3 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,000 Underlying: Common Stock · 67,000 shares Expires 2032-02-22 F4 · derivative.exercise_date: This option award was granted on February 23, 2022. 1/4 of the shares underlying the award shall vest on February 23, 2023, with the remainder of the shares vesting in equal monthly installments following February 23, 2023 through February 23, 2026. Read SEC document |
| December 17, 2021 Filed Dec 21, 2021 21:15 UTC | ARVINAS, INC. ARVN · Entity 5355 | Exercise / conversionStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001209191-21-070872 · doc4.xml · derivative · entry 3 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,384 Underlying: Common Stock · 15,000 shares Expires 2028-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2021. F3 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested on March 31, 2019, with the remainder of the shares vesting in equal monthly installments following March 31, 2019 through March 31, 2022. Read SEC document |
| December 17, 2021 Filed Dec 21, 2021 21:15 UTC | ARVINAS, INC. ARVN · Entity 5355 | SaleCommon Stock | 15,000 | $70.00 | $1,050,000.00 |
DisclosureSEC source: 0001209191-21-070872 · doc4.xml · nonDerivative · entry 2 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,249 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2021. Read SEC document |
| December 17, 2021 Filed Dec 21, 2021 21:15 UTC | ARVINAS, INC. ARVN · Entity 5355 | Exercise / conversionCommon Stock | 15,000 | $16.00 | $240,000.00 |
DisclosureSEC source: 0001209191-21-070872 · doc4.xml · nonDerivative · entry 1 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,249 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2021. Read SEC document |
| July 28, 2021 Filed Jul 30, 2021 20:05 UTC | ARVINAS, INC. ARVN · Entity 5355 | Exercise / conversionStock Option (right to buy) · Derivative | 17,242 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001209191-21-048971 · doc4.xml · derivative · entry 3 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,384 Underlying: Common Stock · 17,242 shares Expires 2028-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020. F3 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested on March 31, 2019, with the remainder of the shares vesting in equal monthly installments following March 31, 2019 through March 31, 2022. Read SEC document |
| July 28, 2021 Filed Jul 30, 2021 20:05 UTC | ARVINAS, INC. ARVN · Entity 5355 | SaleCommon Stock | 17,242 | $100.00 | $1,724,200.00 |
DisclosureSEC source: 0001209191-21-048971 · doc4.xml · nonDerivative · entry 2 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,249 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020. Read SEC document |
| July 28, 2021 Filed Jul 30, 2021 20:05 UTC | ARVINAS, INC. ARVN · Entity 5355 | Exercise / conversionCommon Stock | 17,242 | $16.00 | $275,872.00 |
DisclosureSEC source: 0001209191-21-048971 · doc4.xml · nonDerivative · entry 1 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,491 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020. Read SEC document |
| March 02, 2021 Filed Mar 2, 2021 21:02 UTC | ARVINAS, INC. ARVN · Entity 5355 | Exercise / conversionRestricted Stock Units · Derivative | 4,792 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-009199 · doc4.xml · derivative · entry 4 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,582 Underlying: Common Stock · 4,792 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: On March 1, 2019, the reporting person was granted 19,165 Restricted Stock Units, vesting in four equal annual installments beginning March 1, 2020. F5 · derivative.expiration_date: On March 1, 2019, the reporting person was granted 19,165 Restricted Stock Units, vesting in four equal annual installments beginning March 1, 2020. Read SEC document |
| March 02, 2021 Filed Mar 2, 2021 21:02 UTC | ARVINAS, INC. ARVN · Entity 5355 | SaleCommon Stock | 2,221 | $77.45 | $172,015.34 |
DisclosureSEC source: 0000899243-21-009199 · doc4.xml · nonDerivative · entry 2 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,249 F2 · shares: This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units. F3 · price: The broker sold shares of the Issuer's common stock for certain employees following the vesting of previously granted Restricted Stock Units, including the common stock reported on this Form 4 by the reporting person, at an average price of $77.4495. Read SEC document |
| March 02, 2021 Filed Mar 2, 2021 21:02 UTC | ARVINAS, INC. ARVN · Entity 5355 | Exercise / conversionCommon Stock | 4,792 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-009199 · doc4.xml · nonDerivative · entry 1 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,470 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 21:02 UTC | ARVINAS, INC. ARVN · Entity 5355 | GrantStock Option (right to buy) · Derivative | 68,000 | $0.00 Strike: $78.30 | $0.00 |
DisclosureSEC source: 0000899243-21-009199 · doc4.xml · derivative · entry 3 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 68,000 shares Expires 2031-02-25 F4 · derivative.exercise_date: This option award was granted on February 26, 2021. 1/4 of the shares underlying the award shall vest on February 26, 2022, with the remainder of the shares vesting in equal monthly installments following February 26, 2022 through February 26, 2025. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 17:16 UTC | ARVINAS, INC. ARVN · Entity 5355 | Exercise / conversionStock Option (right to buy) · Derivative | 569 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-21-007149 · doc4.xml · derivative · entry 4 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,127 Underlying: Common Stock · 569 shares Expires 2028-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of January 1, 2019, with the remainder of the shares vesting in equal monthly installments following January 1, 2019 through January 1, 2022. F2 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of June 28, 2019, with the remainder of the shares vesting in equal monthly installments following June 28, 2019 through June 28, 2022. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 17:16 UTC | ARVINAS, INC. ARVN · Entity 5355 | Exercise / conversionStock Option (right to buy) · Derivative | 325 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-21-007149 · doc4.xml · derivative · entry 3 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,192 Underlying: Common Stock · 325 shares Expires 2028-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of January 1, 2019, with the remainder of the shares vesting in equal monthly installments following January 1, 2019 through January 1, 2022. F1 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of January 1, 2019, with the remainder of the shares vesting in equal monthly installments following January 1, 2019 through January 1, 2022. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 17:16 UTC | ARVINAS, INC. ARVN · Entity 5355 | Exercise / conversionCommon Stock | 569 | $16.00 | $9,104.00 |
DisclosureSEC source: 0000899243-21-007149 · doc4.xml · nonDerivative · entry 2 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,678 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of January 1, 2019, with the remainder of the shares vesting in equal monthly installments following January 1, 2019 through January 1, 2022. Read SEC document |
| February 17, 2021 Filed Feb 18, 2021 17:16 UTC | ARVINAS, INC. ARVN · Entity 5355 | Exercise / conversionCommon Stock | 325 | $16.00 | $5,200.00 |
DisclosureSEC source: 0000899243-21-007149 · doc4.xml · nonDerivative · entry 1 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,109 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of January 1, 2019, with the remainder of the shares vesting in equal monthly installments following January 1, 2019 through January 1, 2022. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 17:09 UTC | ARVINAS, INC. ARVN · Entity 5355 | Exercise / conversionStock Option (right to buy) · Derivative | 35,144 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-21-007141 · doc4.xml · derivative · entry 12 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,262 Underlying: Common Stock · 35,144 shares Expires 2028-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020. F12 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested on March 31, 2019, with the remainder of the shares vesting in equal monthly installments following March 31, 2019 through March 31, 2022. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 17:09 UTC | ARVINAS, INC. ARVN · Entity 5355 | Exercise / conversionStock Option (right to buy) · Derivative | 6,815 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-21-007141 · doc4.xml · derivative · entry 11 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,815 shares Expires 2028-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020. F11 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of January 1, 2017 and the remainder of the shares vested in equal monthly installments following January 1, 2017 through January 1, 2020. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 17:09 UTC | ARVINAS, INC. ARVN · Entity 5355 | SaleCommon Stock | 30 | $80.43 | $2,413.04 |
DisclosureSEC source: 0000899243-21-007141 · doc4.xml · nonDerivative · entry 10 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,784 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.42 to $80.86, inclusive. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 17:09 UTC | ARVINAS, INC. ARVN · Entity 5355 | SaleCommon Stock | 1,161 | $79.42 | $92,211.26 |
DisclosureSEC source: 0000899243-21-007141 · doc4.xml · nonDerivative · entry 9 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,814 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.10 to $79.91, inclusive. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 17:09 UTC | ARVINAS, INC. ARVN · Entity 5355 | SaleCommon Stock | 6,160 | $78.65 | $484,462.44 |
DisclosureSEC source: 0000899243-21-007141 · doc4.xml · nonDerivative · entry 8 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,975 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.09 to $79.07, inclusive. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 17:09 UTC | ARVINAS, INC. ARVN · Entity 5355 | SaleCommon Stock | 2,793 | $77.62 | $216,794.62 |
DisclosureSEC source: 0000899243-21-007141 · doc4.xml · nonDerivative · entry 7 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,135 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.05 to $78.04, inclusive. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 17:09 UTC | ARVINAS, INC. ARVN · Entity 5355 | SaleCommon Stock | 396 | $80.28 | $31,791.36 |
DisclosureSEC source: 0000899243-21-007141 · doc4.xml · nonDerivative · entry 6 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,928 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.04 to $80.74, inclusive. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 17:09 UTC | ARVINAS, INC. ARVN · Entity 5355 | SaleCommon Stock | 3,958 | $79.32 | $313,934.31 |
DisclosureSEC source: 0000899243-21-007141 · doc4.xml · nonDerivative · entry 5 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,324 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.04 to $79.91, inclusive. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 17:09 UTC | ARVINAS, INC. ARVN · Entity 5355 | SaleCommon Stock | 19,303 | $78.61 | $1,517,457.09 |
DisclosureSEC source: 0000899243-21-007141 · doc4.xml · nonDerivative · entry 4 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,282 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.04 to $79.03, inclusive. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 17:09 UTC | ARVINAS, INC. ARVN · Entity 5355 | SaleCommon Stock | 8,158 | $77.60 | $633,043.67 |
DisclosureSEC source: 0000899243-21-007141 · doc4.xml · nonDerivative · entry 3 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,585 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.04 to $78.035, inclusive. The reporting person undertakes to provide to Arvinas, Inc., any security holder of Arvinas, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (10) to this Form 4. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 17:09 UTC | ARVINAS, INC. ARVN · Entity 5355 | Exercise / conversionCommon Stock | 35,144 | $16.00 | $562,304.00 |
DisclosureSEC source: 0000899243-21-007141 · doc4.xml · nonDerivative · entry 2 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,743 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 17:09 UTC | ARVINAS, INC. ARVN · Entity 5355 | Exercise / conversionCommon Stock | 6,815 | $16.00 | $109,040.00 |
DisclosureSEC source: 0000899243-21-007141 · doc4.xml · nonDerivative · entry 1 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,599 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 18:00 UTC | ARVINAS, INC. ARVN · Entity 5355 | Exercise / conversionStock Option (right to buy) · Derivative | 2,356 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001209191-20-058093 · doc4.xml · derivative · entry 3 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,696 Underlying: Common Stock · 2,356 shares Expires 2028-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of June 28, 2019, with the remainder of the shares vesting in equal monthly installments following June 28, 2019 through June 28, 2022. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 18:00 UTC | ARVINAS, INC. ARVN · Entity 5355 | Exercise / conversionStock Option (right to buy) · Derivative | 650 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001209191-20-058093 · doc4.xml · derivative · entry 2 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,517 Underlying: Common Stock · 650 shares Expires 2028-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of January 1, 2019, with the remainder of the shares vesting in equal monthly installments following January 1, 2019 through January 1, 2022. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 18:00 UTC | ARVINAS, INC. ARVN · Entity 5355 | Exercise / conversionCommon Stock | 3,006 | $16.00 | $48,096.00 |
DisclosureSEC source: 0001209191-20-058093 · doc4.xml · nonDerivative · entry 1 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,784 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2020 Filed May 14, 2020 21:30 UTC | ARVINAS, INC. ARVN · Entity 5355 | Exercise / conversionStock Option (right to buy) · Derivative | 1,139 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029414 · doc4.xml · derivative · entry 3 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,052 Underlying: Common Stock · 1,139 shares Expires 2028-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of June 28, 2019, with the remainder of the shares vesting in equal monthly installments following June 28, 2019 through June 28, 2022. Read SEC document |
| May 13, 2020 Filed May 14, 2020 21:30 UTC | ARVINAS, INC. ARVN · Entity 5355 | Exercise / conversionStock Option (right to buy) · Derivative | 217 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029414 · doc4.xml · derivative · entry 2 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,167 Underlying: Common Stock · 217 shares Expires 2028-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of January 1, 2019, with the remainder of the shares vesting in equal monthly installments following January 1, 2019 through January 1, 2022. Read SEC document |
| May 13, 2020 Filed May 14, 2020 21:30 UTC | ARVINAS, INC. ARVN · Entity 5355 | Exercise / conversionCommon Stock | 1,356 | $16.00 | $21,696.00 |
DisclosureSEC source: 0001209191-20-029414 · doc4.xml · nonDerivative · entry 1 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,778 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2020 Filed May 14, 2020 21:25 UTC | ARVINAS, INC. ARVN · Entity 5355 | SaleCommon Stock | 10,000 | $60.00 | $600,000.00 |
DisclosureSEC source: 0001209191-20-029413 · doc4.xml · nonDerivative · entry 1 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,422 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 20, 2019. Read SEC document |
| March 23, 2020 Filed Mar 24, 2020 07:30 UTC | ARVINAS, INC. ARVN · Entity 5355 | Exercise / conversionStock Option (right to buy) · Derivative | 758 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001209191-20-020803 · doc4.xml · derivative · entry 4 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,384 Underlying: Common Stock · 758 shares Expires 2028-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of January 1, 2019, with the remainder of the shares vesting in equal monthly installments following January 1, 2019 through January 1, 2022. Read SEC document |
| March 23, 2020 Filed Mar 24, 2020 07:30 UTC | ARVINAS, INC. ARVN · Entity 5355 | Exercise / conversionStock Option (right to buy) · Derivative | 1,139 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001209191-20-020803 · doc4.xml · derivative · entry 3 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,191 Underlying: Common Stock · 1,139 shares Expires 2028-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of June 28, 2019, with the remainder of the shares vesting in equal monthly installments following June 28, 2019 through June 28, 2022. Read SEC document |
| March 23, 2020 Filed Mar 24, 2020 07:30 UTC | ARVINAS, INC. ARVN · Entity 5355 | Exercise / conversionStock Option (right to buy) · Derivative | 6,133 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001209191-20-020803 · doc4.xml · derivative · entry 2 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,815 Underlying: Common Stock · 6,133 shares Expires 2028-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of January 1, 2017, with the remainder of the shares vesting in equal monthly installments following January 1, 2017 through January 1, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.